Latest filing published 26 Mar 2026 for Acadia Pharmaceuticals INC, €71k.
Filing timeline
BuySaleInsider track record
Jennifer J. Rhodes: trading record in brief
Jennifer J. Rhodes discloses dealings in 4 companies, chiefly Medivation, Inc., Adamas Pharmaceuticals Inc and Elicio Therapeutics, Inc. We count 44 filings; the first trade dates from 21 January 2014 and the latest from 25 March 2026.
Sales make up the whole of the open-market record (32 sales, €2.0M). Outside the open market, there are 7 share grants and 5 option exercises. 2026 to date brings no purchases and 2 sales.
Most recently, on 26 March 2026, the filings show an open-market sale worth €71k in Acadia Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jennifer J. Rhodes
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,844 shares@ US$21.4734.1% of flowCommon StockSEC:0001568249-26-000005:1
- 7,515 shares0Common StockSEC:0001568249-26-000005:0
- 6,950 shares@ US$23.38100.0% of flowCommon StockSEC:0001568249-26-000002:1
- 12,944 shares0Common StockSEC:0001568249-26-000002:0
- 451 shares@ US$2.41713.1% of flowCommon StockSEC:0001601485-21-000083:0
- 433 shares@ US$4.405.3% of flowCommon StockSEC:0001601485-21-000072:0
- 430 shares@ US$8.6510.2% of flowCommon StockSEC:0001601485-21-000060:0
- 430 shares@ US$10.6412.3% of flowCommon StockSEC:0001601485-21-000056:0
- 445 shares@ US$10.6812.8% of flowCommon StockSEC:0001601485-21-000050:0
- 432 shares@ US$10.9412.7% of flowCommon StockSEC:0001601485-21-000040:0
- 431 shares@ US$11.0112.7% of flowCommon StockSEC:0001601485-21-000033:0
- 427 shares@ US$13.2714.8% of flowCommon StockSEC:0001601485-21-000027:0
- 440 shares@ US$13.9216.1% of flowCommon StockSEC:0001601485-21-000023:0
- 399 shares@ US$15.019.5% of flowCommon StockSEC:0001601485-21-000011:0
- 499 shares@ US$20.4516.3% of flowCommon StockSEC:0001567619-21-006400:0
- 457 shares@ US$19.5414.0% of flowCommon StockSEC:0001567619-21-004331:0
- 940 shares@ US$5.3522.4% of flowCommon StockSEC:0001209191-19-038602:0
- 30,000 shares0Common StockSEC:0001209191-19-024244:0
- 1,792 shares@ US$7.9930.1% of flowCommon StockSEC:0001209191-19-020769:0
- 425 shares@ US$7.524.5% of flowCommon StockSEC:0001209191-18-063937:0
- 1,002 shares@ US$25.4824.2% of flowCommon StockSEC:0001209191-18-039257:0
- 982 shares@ US$25.8922.8% of flowCommon StockSEC:0001209191-18-021317:0
- 6,250 shares0Common StockSEC:0001209191-18-018676:0
- 440 shares@ US$32.3013.2% of flowCommon StockSEC:0001209191-17-066810:0
- 1,041 shares@ US$17.5318.0% of flowCommon StockSEC:0001209191-17-041439:0
25 of 44 declarations
